| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/30/2010 | US20100249110 Substituted pyrazolo-pyrimidine compounds |
| 09/30/2010 | US20100249108 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds |
| 09/30/2010 | US20100249105 Indole and indoline derivatives and methods of use thereof |
| 09/30/2010 | US20100249095 Substituted Spiro-amide Compounds |
| 09/30/2010 | US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 09/30/2010 | US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 09/30/2010 | US20100248241 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 09/30/2010 | US20100244670 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same |
| 09/30/2010 | US20100242792 Synthesis of colorants in mixing apparatus |
| 09/30/2010 | CA2756172A1 Inhibitors of hepatitis c virus replication |
| 09/30/2010 | CA2756152A1 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 09/30/2010 | CA2756064A1 Process for the production of fused, tricyclic sulfonamides |
| 09/30/2010 | CA2755910A1 Inhibitors of nf-kb |
| 09/30/2010 | CA2755680A1 P2x3, receptor antagonists for treatment of pain |
| 09/30/2010 | CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 09/30/2010 | CA2754154A1 Method for the industrial purification of biologically active phycotoxins |
| 09/29/2010 | EP2233487A1 Spirocyclic cyclohexane derivatives |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | EP2233484A2 Oxazolidinone derivatives having a 7-membered heterocyclic ring |
| 09/29/2010 | EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 09/29/2010 | EP2231668A1 Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections |
| 09/29/2010 | EP2231667A2 Beta-lactamase inhibitors |
| 09/29/2010 | EP2231666A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 09/29/2010 | EP2231665A2 Novel compositions and methods of use |
| 09/29/2010 | EP2231664A1 4-(pyrroloý2,3-c¨pyridine-3-yl)-pyrimidine-2-amine derivatives |
| 09/29/2010 | EP2231663A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 09/29/2010 | EP2231662A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 09/29/2010 | EP2231661A1 Inhibitors of pi3 kinase |
| 09/29/2010 | EP2231660A1 Imidazo [1,2-a] pyridine compounds |
| 09/29/2010 | EP2231653A1 Antibacterial condensed thiazoles |
| 09/29/2010 | EP2231629A1 Modulators for amyloid beta |
| 09/29/2010 | EP2231282A1 Protein kinase inhibitors and use thereof |
| 09/29/2010 | EP2231280A2 Organic compounds |
| 09/29/2010 | EP2231143A1 Inhibitors of janus kinases |
| 09/29/2010 | EP2099797B1 Compounds and compositions as protein kinase inhibitors |
| 09/29/2010 | EP1960398B1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 09/29/2010 | EP1917265B1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF |
| 09/29/2010 | EP1907484B1 Naphthalene amidine imides |
| 09/29/2010 | EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 09/29/2010 | EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/29/2010 | EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 09/29/2010 | CN1972938B 环状胺化合物 Cyclic amine compound |
| 09/29/2010 | CN1953978B 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
| 09/29/2010 | CN101848910A 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 09/29/2010 | CN101848909A Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases |
| 09/29/2010 | CN101845023A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 09/29/2010 | CN101130541B Method for extracting and separating matrine and oxymatrine from trialkyl phosphine oxide inverse micellar solution |
| 09/29/2010 | CN101068812B Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 09/29/2010 | CN101061110B Heterlcyclic diamide insecticides |
| 09/29/2010 | CN101006087B Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 09/29/2010 | CN101006086B 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido'2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 09/28/2010 | US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | US7803810 Inhibitors |
| 09/28/2010 | US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 09/28/2010 | US7803197 useful for the dyeing of organic materials, such as keratin fibers, preferably human hair |
| 09/28/2010 | CA2504614C Process for the preparation of imidazolyl compounds |
| 09/28/2010 | CA2395772C Sulfonamide-containing heterocyclic compounds |
| 09/28/2010 | CA2387016C Acrylamide derivatives as fab i inhibitors |
| 09/28/2010 | CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 09/28/2010 | CA2382247C Azaindoles having serotonin receptor affinity |
| 09/28/2010 | CA2376304C Amide substituted imidazoquinolines |
| 09/23/2010 | WO2010108074A2 Inhibitors of pi3 kinase |
| 09/23/2010 | WO2010107115A1 Glycine transporter inhibitor |
| 09/23/2010 | WO2010106333A1 Compounds |
| 09/23/2010 | WO2010025872A3 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl |
| 09/23/2010 | WO2010009155A3 Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| 09/23/2010 | WO2009132774A8 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 09/23/2010 | US20100240924 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides |
| 09/23/2010 | US20100240897 Spirocyclic Cyclohexane Compounds |
| 09/23/2010 | US20100240696 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/23/2010 | US20100240694 Salt of naphthyridine carboxylic acid derivative |
| 09/23/2010 | US20100240692 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 09/23/2010 | US20100240666 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 09/23/2010 | US20100240663 Heterocycles as potassium channel modulators |
| 09/23/2010 | US20100240657 Chemical compounds |
| 09/23/2010 | US20100240613 Pyrimidine compound and medical use thereof |
| 09/23/2010 | US20100239551 Compounds and compositions as channel activating protease inhibitors |
| 09/23/2010 | US20100239527 2,3-substituted azaindole derivatives for treating viral infections |
| 09/23/2010 | US20100239526 Substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds |
| 09/23/2010 | US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| 09/23/2010 | US20100239522 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway |
| 09/23/2010 | US20100237328 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME |
| 09/23/2010 | US20100237298 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators |
| 09/23/2010 | CA2755285A1 Inhibitors of pi3 kinase |
| 09/23/2010 | CA2754605A1 Compounds |
| 09/23/2010 | CA2754509A1 Novel anti-inflammatory agents |
| 09/22/2010 | EP2229391A1 Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
| 09/22/2010 | EP2229390A1 Novel imidazoý1,2-a¨pyridine and imidazoý1,2-b¨pyridazine derivatives |
| 09/22/2010 | EP2229381A1 Gamma secretase modulators |
| 09/22/2010 | EP2229375A1 Gamma secretase modulators |
| 09/22/2010 | EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 09/22/2010 | EP2076506B1 Heterocyclic-substituted piperidines as orl-1 ligands |
| 09/22/2010 | EP1978967B1 Quinazolinone derivatives as vanilloid antagonists |
| 09/22/2010 | EP1796669B1 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/22/2010 | EP1682549B1 Imidazo[1,2-a]pyridine anxiolytics |
| 09/22/2010 | CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 09/22/2010 | CN101842374A 2,3-substituted azaindole derivatives for treating viral infections |